Zeit Capital’s Bristol-Myers Squibb BMY Stock Holding History

Zeit Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$331K	Hold	2,028	–	–	0.2%	21
2026 Q1	$412K	Buy	+2,028	New	+$118K	0.28%	19

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Zeit Capital's BMY Position: Q2 2026 in Review

Zeit Capital held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 2,028 shares worth $331K. The position accounts for 0.2% of the portfolio, ranked #21.

Zeit Capital first reported a position in BMY in Q1 2026 and has held it in 2 quarters since. The position peaked at $412K in Q1 2026. 2,502 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Zeit Capital held 2,028 shares of Bristol-Myers Squibb worth $331K as of Q2 2026.
Zeit Capital left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up 0.2% of Zeit Capital's portfolio in Q2 2026, its #21 holding.
Zeit Capital first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 2 quarters since.
Zeit Capital's Bristol-Myers Squibb position peaked at $412K in Q1 2026.
2,502 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Zeit Capital's 13F filing for Q2 2026, filed 6 Aug 2026.